These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 17540436

  • 1. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 3. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, Jacobs IJ, Høgdall CK.
    Gynecol Oncol; 2007 Mar; 104(3):508-15. PubMed ID: 17113137
    [Abstract] [Full Text] [Related]

  • 4. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 5. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK.
    Cancer; 2003 Jul 01; 98(1):66-73. PubMed ID: 12833457
    [Abstract] [Full Text] [Related]

  • 6. P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK.
    Gynecol Oncol; 2006 Jan 01; 100(1):76-82. PubMed ID: 16183105
    [Abstract] [Full Text] [Related]

  • 7. Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Høgdall CK.
    APMIS; 2010 Aug 01; 118(8):557-64. PubMed ID: 20666736
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun 01; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 9. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
    Gilks CB, Ionescu DN, Kalloger SE, Köbel M, Irving J, Clarke B, Santos J, Le N, Moravan V, Swenerton K, Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency.
    Hum Pathol; 2008 Aug 01; 39(8):1239-51. PubMed ID: 18602670
    [Abstract] [Full Text] [Related]

  • 10. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
    Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K.
    Gynecol Oncol; 2006 Apr 01; 101(1):12-7. PubMed ID: 16263157
    [Abstract] [Full Text] [Related]

  • 11. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A, Pirvulescu C, Könsgen D, Braicu EI, Yuan S, Sun P, Lichtenegger W, Sehouli J.
    Cytokine; 2008 Apr 01; 42(1):77-84. PubMed ID: 18329282
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC, Høgdall CK, Kjaer SK, Christensen L, Jensen A, Blaakaer J, Christensen IJ, Høgdall EV.
    APMIS; 2013 Dec 01; 121(12):1177-86. PubMed ID: 23594232
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group.
    Cancer; 2008 May 15; 112(10):2202-10. PubMed ID: 18348296
    [Abstract] [Full Text] [Related]

  • 14. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
    Cancer Res; 2001 Nov 01; 61(21):7811-8. PubMed ID: 11691797
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.
    Karamurzin Y, Leitao MM, Soslow RA.
    Am J Surg Pathol; 2013 Mar 01; 37(3):356-67. PubMed ID: 23282975
    [Abstract] [Full Text] [Related]

  • 16. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS.
    Gynecol Oncol; 2008 Jun 01; 109(3):370-6. PubMed ID: 18395777
    [Abstract] [Full Text] [Related]

  • 17. Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.
    Heeran MC, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Christensen IJ, Hogdall EV.
    APMIS; 2012 Oct 01; 120(10):846-54. PubMed ID: 22958293
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK.
    Cancer; 2004 Jun 01; 100(11):2387-95. PubMed ID: 15160342
    [Abstract] [Full Text] [Related]

  • 19. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M, Rakar S, Klancnik B, Syrjänen K.
    Gynecol Oncol; 2001 Oct 01; 83(1):100-8. PubMed ID: 11585420
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancer.
    Koensgen D, Mustea A, Denkert C, Sun PM, Lichtenegger W, Sehouli J.
    Anticancer Res; 2006 Oct 01; 26(2C):1683-9. PubMed ID: 16617562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.